Thiazole derivatives and use thereof

Details for Australian Patent Application No. 2005205201 (hide)

Owner Merck Serono SA

Inventors Dorbais, Jerome; Rueckle, Thomas; Sauer, Wolfgang; Schwarz, Matthias; Cleva, Christophe; Desforges, Gwenaelle; Quattropani, Anna

Agent Griffith Hack

Pub. Number AU-B-2005205201

PCT Pub. Number WO2005/068444

Priority 04100083.7 12.01.04 EP

Filing date 11 January 2005

Wipo publication date 28 July 2005

Acceptance publication date 12 May 2011

International Classifications

C07D 277/46 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

13 July 2006 PCT application entered the National Phase

  PCT publication WO2005/068444 Priority application(s): WO2005/068444

25 October 2007 Assignment before Grant

  Applied Research Systems ARS Holding N.V. The application has been assigned to Laboratoires Serono SA Assignments before Grant, Section 113

30 April 2009 Alteration of Name

  The name of the applicant has been altered to Merck Serono SA Amendments

12 May 2011 Application Accepted

  Published as AU-B-2005205201

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005205218-Methods of assessing a tissue inflammatory response using expression profiles of endothelial cells

2005205192-Orientated acrylate adhesive materials, method for the production and use thereof